Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trunnano, officially Luoyang Tongrun Info Technology Co., Ltd., is a global leader in the manufacturing and supply of high-purity nanomaterials and chemical functional materials. The company specializes in the synthesis of metal nanoparticles, oxides, carbides, and borides used across diverse sectors including aerospace, energy, and healthcare. In the life sciences field, Trunnano provides critical biomaterials such as hydroxyapatite for bone tissue engineering and silver nanoparticles for antimicrobial applications in medical devices. Their expertise in nanotechnology allows for the production of materials with precise particle sizes and high surface areas, supporting advanced research in drug delivery and medical implants. Trunnano operates as a key supplier to pharmaceutical and medical device companies worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trunnano.